FDA says this weight loss drug shortage is over

Women turn to weight loss drugs in menopause: What to know about the benefits and risks
Losing weight in menopause can help with the severity of other menopause symptoms like hot flashes and night sweats, according to Shepherd. The average age for menopause, when your periods stop permanently, is 52, according to the U.S. Office on Women's Health. Menopause is reached after it has been a full year since your last period.
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known about their long-term effects
Amid backlash, FDA changes course over shortage of weight-loss drugs
The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper versions. After an outcry, it’s reconsidering.
Drugs Like Ozempic Were Made For Major Weight Loss. But Could You Use It To Lose 10 Pounds?
Many people use semaglutides like Ozempic for weight loss, but can you use it to lose a small amount—say, 10 or 20 pounds? Doctors explain the concerns.
Opinion
Reher: Counterfeit weight-loss drug crisis looms
Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these drugs, nearly indistinguishable from the real thing.
Latest weight-loss drug faces shortages
The United States Food and Drug Administration (FDA) says that high demand has left the latest weight-loss drug, Zepbound, in short supply.
Ozempic maker Novo Nordisk wants the FDA to crack down on knockoff weight loss drugs
Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies from making off-brand versions of semaglutide, the active ingredient in its blockbuster weight loss and diabetes medications.
Eli Lilly Sues Over Knock-Off Weight-Loss Drugs
Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their drug, Zepbound.
MangoRx hits back at Eli Lilly’s weight loss drug copycat claims
MangoRx was responding to Eli Lily after the drugmaker sued it and two other medical spas and online vendors earlier this week for selling products claiming to contain tirzepatide
FDA's Weight Loss Drug 'No Man's Land' Adds Risk for Compounders
Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions ...
Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies
Oct 23 (Reuters) - Novo Nordisk (NOVOb.CO) on Tuesday asked the U.S. Food and Drug Administration to ban compounding ...
MassDevice2d
Allurion submits weight loss balloon modules to the FDA for premarket approval
Allurion Technologies announced today that it submitted three modules for its weight loss balloon to the FDA for premarket ...
AOL12d
FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace ... Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions on the ...